Growth Metrics

Erasca (ERAS) Other Gross PP&E Adjustments (2020 - 2026)

Erasca posted quarterly Other Gross PP&E Adjustments of -$2.8 million for Q1 2026, up 48.82% year-on-year from -$1.9 million in Q1 2025, and up 16.25% on a QoQ basis from -$3.3 million in Q4 2025.

Erasca (ERAS) has 7 years of Other Gross PP&E Adjustments data on file, last reported at -$2.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 48.82% year-over-year to -$2.8 million; the trailing twelve-month figure through Mar 2026 stood at -$2.8 million (up 48.82% YoY), and the FY2025 full-year result was -$3.3 million, up 74.38% from the prior year.
  • Other Gross PP&E Adjustments for Q1 2026 stood at -$2.8 million, up from -$3.3 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $10.7 million in Q2 2022 and bottomed at -$16.1 million in Q4 2022.
  • The 5-year median for Other Gross PP&E Adjustments is -$7.7 million (2024), against an average of -$6.7 million.
  • Peak annual rise in Other Gross PP&E Adjustments reached 850.13% in 2022, while the deepest fall reached 2516.29% in 2022.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$16.1 million in 2022, then grew by 23.38% to -$12.3 million in 2023, then dropped by 4.59% to -$12.9 million in 2024, then surged by 74.38% to -$3.3 million in 2025, then rose by 16.25% to -$2.8 million in 2026.
  • The last three Other Gross PP&E Adjustments figures came in at -$2.8 million (Q1 2026), -$3.3 million (Q4 2025), and -$4.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -60,691.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -892,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -189.30 Mn
10 Erasca 4.21 Bn 3.97 Bn - -2.76 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.76 Mn
Mar 31, 2026 -2.76 Mn
Dec 31, 2025 -3.30 Mn
Dec 31, 2025 -3.30 Mn
Sep 30, 2025 -4.55 Mn
Sep 30, 2025 -4.55 Mn
Jun 30, 2025 -4.90 Mn
Jun 30, 2025 -4.90 Mn
Mar 31, 2025 -5.40 Mn
Mar 31, 2025 -5.40 Mn
Dec 31, 2024 -12.87 Mn
Dec 31, 2024 -12.87 Mn
Sep 30, 2024 -6.98 Mn
Sep 30, 2024 -6.98 Mn
Jun 30, 2024 -7.73 Mn
Jun 30, 2024 -7.73 Mn
Mar 31, 2024 -8.22 Mn
Mar 31, 2024 -8.22 Mn
Dec 31, 2023 -12.31 Mn
Dec 31, 2023 -12.31 Mn
Sep 30, 2023 -9.36 Mn
Sep 30, 2023 -9.36 Mn
Jun 30, 2023 -10.49 Mn
Jun 30, 2023 -10.49 Mn
Mar 31, 2023 -11.12 Mn
Mar 31, 2023 -11.12 Mn
Dec 31, 2022 -16.06 Mn
Dec 31, 2022 -16.06 Mn
Sep 30, 2022 -14.66 Mn
Sep 30, 2022 -14.66 Mn
Jun 30, 2022 10.75 Mn
Jun 30, 2022 10.75 Mn
Mar 31, 2022 5.40 Mn
Mar 31, 2022 5.40 Mn
Dec 31, 2021 -614,000.00
Dec 31, 2021 -614,000.00
Sep 30, 2021 -9.29 Mn
Sep 30, 2021 -9.29 Mn
Jun 30, 2021 1.13 Mn
Jun 30, 2021 1.13 Mn
Dec 31, 2020 330,000.00
Dec 31, 2020 330,000.00